NO134616B - - Google Patents

Download PDF

Info

Publication number
NO134616B
NO134616B NO17100867A NO17100867A NO134616B NO 134616 B NO134616 B NO 134616B NO 17100867 A NO17100867 A NO 17100867A NO 17100867 A NO17100867 A NO 17100867A NO 134616 B NO134616 B NO 134616B
Authority
NO
Norway
Prior art keywords
dibenzo
methyl
compounds
hydroxy
ether
Prior art date
Application number
NO17100867A
Other languages
Norwegian (no)
Other versions
NO134616C (en
Inventor
G Rey-Bellet
H Spiegelberg-Schoop
Original Assignee
Kefalas As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH146761A external-priority patent/CH419104A/en
Application filed by Kefalas As filed Critical Kefalas As
Priority to NO17100867A priority Critical patent/NO134616C/no
Publication of NO134616B publication Critical patent/NO134616B/no
Publication of NO134616C publication Critical patent/NO134616C/no

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

Nærværende oppfinnelse vedrorer en analogifremgangsmåte for fremstilling av 5-(y-sekundæraminopropyliden)-dibenzoheptaen-forbindelser med den generelle formel The present invention relates to an analogous process for the preparation of 5-(γ-secondary aminopropylidene)-dibenzoheptaene compounds of the general formula

hvor den stiplede binding kan være hydrogenert, betyr en alkylrest med inntil 4 karbonatomer, fortrinnsvis metyl eller etyl, where the dotted bond may be hydrogenated, means an alkyl residue with up to 4 carbon atoms, preferably methyl or ethyl,

1*2 hydrogen eller halogen og1*2 hydrogen or halogen and

A en eventuelt med en alkylrest med inntil 4 A optionally with an alkyl residue with up to 4

karbonatomer substituert etylenrest,carbon atoms substituted ethylene residue,

og deres syreaddisjonssalter.and their acid addition salts.

Fremgangsmåten karakteriseres ved at man dehydratiserer en forbindelse med den generelle formel The method is characterized by dehydrating a compound with the general formula

hvor den stiplede binding kan være hydrogenert, og wherein the dotted bond may be hydrogenated, and

Rl'R2 °^ A 'nar f°ran angitte betydning,Rl'R2 °^ A 'when previously indicated meaning,

og overforer eventuelt de erholdte forbindelser til deres syreaddisjonssalter. and optionally transfer the obtained compounds to their acid addition salts.

De som utgangsstoffer nodvendige forbindelser med formel II lar seg f.eks. fremstille på folgende måte: a) Et eventuelt halogensubstituert dibenzo/~a,e7cyklohepta /~1, 57dien-5-on, henh. dibenzo/~a, e7cyklohepta/~l, 3, j>7trien-5-on omsettes ved hjelp av en metallorganisk reaksjon med et alkylbenzyl-aminoalkylhalogenid, og reaksjonsproduktet debenzyleres etter hydrogenolyse. Det forste trinn av denne reaksjon kan f.eks. forlope via magnesium-, litium- eller sink-organiske metallforbindelser. De med fordel anvendte magnesiumforbindelser av alkyl-benzyl-aminoalkyl-halogenider lar seg f.eks. oppnå ved direkte omsetning av spesielt aktivt magnesium, f.eks. i form av ehfint fordelt kobbermagnesium-legering med en eterisk opplosning av halogenidet. Det er derved hensiktsmessig å stimulere omsetningen ved tilsetning av et egnet alkylhalogenid, som f.eks. metyljodid eller etyl-bromid. Hydrolysen av det metallorganiske kompleks finner fortrinnsvis sted under praktisk talt noytrale betingelser, d.v.s. f.eks. ved hjelp av ammoniumklorid. Avspaltningen av benzylgruppen finner hensiktsmessig sted ved hydrogenolyse i nærvær av edelmetallkatalysatorer, fortrinnsvis i en lavere-alifatisk alkohol med palladiumkull, ved oket hydrogentrykk og oket temperatur. Ved denne behandling blir de i ring-skjelettet tilstedeværende flerdobbeltbindinger uangrepne. b) Ved omsetning av et eventuelt halogensubstituert dibenzo /~a, e7cyklohepta/~l, 57dien-5-on henh. dibenzo/~a, ej?cyklohepta /~1,3,57trien-5-on med en alkalimetallforbindelse med formel The compounds of formula II required as starting materials can e.g. prepared in the following way: a) An optionally halogen-substituted dibenzo/~a,e7cyclohepta/~1,57dien-5-one, acc. dibenzo/~a,e7cyclohepta/~l,3,j>7trien-5-one is reacted by means of an organometallic reaction with an alkylbenzyl-aminoalkyl halide, and the reaction product is debenzylated after hydrogenolysis. The first step of this reaction can e.g. proceed via magnesium, lithium or zinc organometallic compounds. The advantageously used magnesium compounds of alkyl-benzyl-aminoalkyl-halides allow e.g. achieved by direct conversion of particularly active magnesium, e.g. in the form of finely divided copper-magnesium alloy with an ethereal solution of the halide. It is therefore appropriate to stimulate the turnover by adding a suitable alkyl halide, such as e.g. methyl iodide or ethyl bromide. The hydrolysis of the organometallic complex preferably takes place under practically neutral conditions, i.e. e.g. using ammonium chloride. The removal of the benzyl group conveniently takes place by hydrogenolysis in the presence of noble metal catalysts, preferably in a lower aliphatic alcohol with palladium charcoal, at increased hydrogen pressure and increased temperature. With this treatment, the multiple bonds present in the ring skeleton remain unattacked. b) When reacting an optionally halogen-substituted dibenzo /~a,e7cyclohepta/~1,57dien-5-one acc. dibenzo/~a, ej?cyclohepta /~1,3,57trien-5-one with an alkali metal compound of the formula

hvor R^<1>betyr en alkylrest med inntil 4 karbonatomer, where R^<1>means an alkyl residue with up to 4 carbon atoms,

R^hydrogen eller en alkylrest med inntil 4 karbonatomer og R^hydrogen or an alkyl residue with up to 4 carbon atoms and

Me et alkalimetall,Me an alkali metal,

og etterfolgende hydrolyse når man til forbindelser med formel and subsequent hydrolysis leads to compounds of formula

hvor R1', R2og R^ har foran angitte betydning og den stiplede binding kan være hydrogenert. where R1', R2 and R^ have the above meaning and the dashed bond may be hydrogenated.

Denne omsetning gjennomfores med fordel via en natrium-, kalium- eller litium-forbindelse. Hensiktsmessig tilsetter man de tricykliske ketoner enten i fast, fint pulverisert form eller i et indifferent opplosningsmiddel, som f ieks. absolutt eter, benzen eller tetrahydrofuran, til den i flytende ammoniakksuspenderte alkalimetallorganiske forbindelse med formel III. Spaltningen av den dannede organiske metall-forbindelse finner med fordel sted under praktisk talt noytrale betingelser f.eks. ved hydrolyse med fast ammoniumklorid eller i vandig ammoniumkloridopplosning. This conversion is advantageously carried out via a sodium, potassium or lithium compound. Appropriately, the tricyclic ketones are added either in solid, finely powdered form or in an indifferent solvent, such as absolute ether, benzene or tetrahydrofuran, to the alkali metal organic compound of formula III suspended in liquid ammonia. The cleavage of the metal-organic compound formed advantageously takes place under practically neutral conditions, e.g. by hydrolysis with solid ammonium chloride or in aqueous ammonium chloride solution.

På denne måte oppnås de dannede, tertiære aminogrupper inne-holdende dibenzo/~a,e7cyklohepta/~l,57dien- eller dibenzo/~a,e7 cyklohepta/~l,3,57trien-forbindelser direkte i fri form og kan ved behandling med egnede, med vann ikke blandbare organiske opplosningsmidler, som f.eks. eter, eddiksyreetylester, kloroform, metylenklorid, skilles og isoleres fra biproduktene ved reaksjonen. In this way, the formed tertiary amino groups containing dibenzo/~a,e7cyclohepta/~1,57diene or dibenzo/~a,e7cyclohepta/~1,3,57triene compounds are obtained directly in free form and can by treatment with suitable, water-immiscible organic solvents, such as e.g. ether, acetic acid ethyl ester, chloroform, methylene chloride, are separated and isolated from the by-products of the reaction.

De erholdte produkter modifiseres ved den etterfolgende hydrogenering på den ene side ved den tredobbelt umettede binding i sidekjeden og debenzyleres på den annen side. Hydrogeneringen gjennomfores hensiktsmessig under de under a) beskrevne betingelser. The products obtained are modified by the subsequent hydrogenation on the one hand at the triple unsaturated bond in the side chain and debenzylated on the other hand. The hydrogenation is appropriately carried out under the conditions described under a).

Dehydratiseringen av forbindelser med formel JI utfores spesielt fordelaktig under oppvarming ved hjelp av alkoholisk saltsyre. Den lykkes imidlertid også med de vanlige andre reagenser, The dehydration of compounds of formula JI is particularly advantageously carried out under heating with the aid of alcoholic hydrochloric acid. However, it also succeeds with the usual other reagents,

som f.eks. med fosforoksyklorid, p-toluensulfoklorid, svovelsyre, sinkklorid, kaliumbisulfat osv. i inerte organiske opplosningsmidler, som f.eks. kloroform og metylenklorid. like for example. with phosphorus oxychloride, p-toluene sulphochloride, sulfuric acid, zinc chloride, potassium bisulphate etc. in inert organic solvents, such as e.g. chloroform and methylene chloride.

De etter fremgangsmåten ifolge oppfinnelsen erholdte tricykliske forbindelser består, såfremt den ene aromatiske ringen er substituert med halogen og/eller sidekjeden i 5-stilling er forgrenet, av en isomerblanding. Denne kan skilles etter i og for seg kjente metoder, f.eks. på grunn av forskjellig opp-loselighet av basene eller addisjonssaltene ved fraksjonert krystallisasjon i cis-, trans- og/eller optisk aktive anti-poder . The tricyclic compounds obtained by the method according to the invention consist, provided that one aromatic ring is substituted with halogen and/or the side chain in the 5-position is branched, of a mixture of isomers. This can be separated according to methods known in and of themselves, e.g. due to different solubility of the bases or addition salts by fractional crystallization in cis-, trans- and/or optically active anti-pods.

Oppfinnelsen omfatter også fremstillingen av syreaddisjons-. salter av de foran nevnte tricykliske forbindelser. Slike salter er f.eks. de med uorganiske syrer, som klorhydrogen-syre, bromhydrogensyre, svovelsyre, og de med organiske syrer, som f.eks. eddiksyre, oksalsyre, sitronsyre, melkesyre, vinsyre. The invention also covers the production of acid addition-. salts of the aforementioned tricyclic compounds. Such salts are e.g. those with inorganic acids, such as hydrochloric acid, hydrobromic acid, sulfuric acid, and those with organic acids, such as e.g. acetic acid, oxalic acid, citric acid, lactic acid, tartaric acid.

De ifolge oppfinnelsen erholdte forbindelser utmerker seg ved de mangfoldige virkninger på nervesystemet. Således er nar-kosepotenserende, adrenolytiske, sedative, antihistaminlig-nende, antiemetiske, antipyretiske, lokal-anestetiske og hypoterme virkninger fastslått. Spesielt påfallende er den raske virkningsinntreden ved administrasjon av disse substanser. The compounds obtained according to the invention are distinguished by their diverse effects on the nervous system. Thus, anesthetic potentiating, adrenolytic, sedative, antihistamine-like, antiemetic, antipyretic, local anesthetic and hypothermic effects have been established. Particularly striking is the rapid onset of action when these substances are administered.

Særlig foretrukket er 5-(31-metylamiho-propyliden)-dibenzo /~a, e7cyklohepta/~l,57dien og dets syreaddisjonssalter, da disse forbindelser oppviser en særlig gunstig kombinasjon av terapeutiske egenskaper. Particularly preferred are 5-(31-methylaminopropylidene)-dibenzo[alpha],[beta]cyclohepta[beta]1,57diene and its acid addition salts, as these compounds exhibit a particularly favorable combination of therapeutic properties.

Ved norsk patent nr. 112.olo, som ikke tilhorer teknikkens stand, er beskyttet en annen fremgangsmåte for fremstilling av bl.a. forbindelsene med formel I ovenfor. Norwegian patent no. 112.olo, which does not belong to the state of the art, protects another method for the production of i.a. the compounds of formula I above.

EKSEMPEL 1EXAMPLE 1

2 g 5-hydroksy-5-(31-metylamino-propyl)-dibenzo/<->a,e7cyklo-hepta/~l,J57dien, 2o ml absolutt alkohol og 2 ml av en 2o%'ig saltsyreopplosning i alkohol oppvarmes i 3 timer på dampbad under tilbakelopskjoling og opplosningen dampes inn til torrhet under forminsket trykk. Resten lar seg omkrystallisere fra etanol-eter og gir 5-(3<1->metylamino-propyliden)-dibenzo/~a,d7 cyklohepta/~l, _5_7dienhydroklorid med smeltepunkt 22o - 222°. 2 g of 5-hydroxy-5-(31-methylamino-propyl)-dibenzo[->a,e7cyclo-hepta]~1,J57diene, 20 ml of absolute alcohol and 2 ml of a 20% hydrochloric acid solution in alcohol are heated in 3 hours in a steam bath under reflux and the solution is evaporated to dryness under reduced pressure. The residue can be recrystallized from ethanol-ether and gives 5-(3<1->methylamino-propylidene)-dibenzo/~a,d7 cyclohepta/~1,_5_7diene hydrochloride with melting point 22o - 222°.

Det som utgangsforbindelse anvendte 5-hydroksy-5-(3<1->metyl-amino-propyl) -dibenzo/~a,e7cyklohepta/~l/57dien kan fremstilles som folger: I en 1-liters trehalskolbe som er forsynt med rorer, dråpe-trakt og kjoler, overdekkes lo g Gilman-legering med 2o ml torr eter og tilsettes o,5 ml metyljodid. The 5-hydroxy-5-(3<1->methyl-amino-propyl)-dibenzo/~a,e7cyclohepta/~1/57diene used as starting compound can be prepared as follows: In a 1-liter three-necked flask fitted with stirrups , dropping funnel and skirts, cover the Gilman alloy with 20 ml of dry ether and add 0.5 ml of methyl iodide.

Etter at den livlige reaksjon har tatt noe av, tilsettes dråpevis en opplosning av 6o g l-klor-3-(metyl-benzyl-amino)-propan i 18o ml torr eter slik at reaksjonsblandingen holdes i kok. Den kokes ytterligere i 4 timer ved 45° under tilbakelop. After the lively reaction has subsided, a solution of 60 g of 1-chloro-3-(methyl-benzyl-amino)-propane in 180 ml of dry ether is added dropwise so that the reaction mixture is kept at a boil. It is boiled for a further 4 hours at 45° under reflux.

Derpå avkjoles reaksjonsblandingen med isvann, en opplosning av 21,2 g dibenzo/~a,d7cyklohepta/~l,57dien-5-on i 25o ml torr eter tilsettes dråpevis i lopet av 1 time, og det hele rores ytterligere i 17 timer under tilbakelop ved 4o°. Den folgende dag avkjoles enda en gang med isvann og reaksjonsblandingen tilsettes en kold, mettet ammoniumkloridopplosning. Det organiske sjikt skilles fra, den vandige fase rystes ut The reaction mixture is then cooled with ice water, a solution of 21.2 g of dibenzo[a,d7cyclohepta[l,57dien-5-one in 250 ml of dry ether is added dropwise over the course of 1 hour, and the whole is stirred for a further 17 hours under reflux at 4o°. The following day, it is cooled once more with ice water and a cold, saturated ammonium chloride solution is added to the reaction mixture. The organic layer is separated, the aqueous phase is shaken out

to ganger, hver gang med 15o ml eter og de forenede eterporsjoner torkes over natriumsulfat og dampes inn. Resten gir etter omkrystallisasjon fra hbytkokende petroleter fargelbse krystaller av 5-hydroksy-5-/~3'-(metyl-benzyl-amino)-propyl7-dibenzo/~a,e7cyklohepta/~l,57dien. Utbytte 73%. twice, each time with 15o ml of ether and the combined ether portions are dried over sodium sulfate and evaporated. The residue gives, after recrystallization from high-boiling petroleum ether, colorless crystals of 5-hydroxy-5-[3'-(methyl-benzyl-amino)-propyl7-dibenzo[a,e7cyclohepta][1,57diene. Yield 73%.

11,5 g 5-hydroksy-5-/~3'-(metyl-benzyl-amino)-propyl27-dibenzo /~a,e7cyklohepta/~l,57dien opploses i 9o ml metanol og hydrogeneres i nærvær av 3 g palladiumkull i 8 timer ved loo° under loo atm. Når hydrogeneringen er ferdig, filtreres opplosningen 11.5 g of 5-hydroxy-5-[3'-(methyl-benzyl-amino)-propyl27-dibenzo/~a,e7cyclohepta/~1,57diene are dissolved in 90 ml of methanol and hydrogenated in the presence of 3 g of palladium charcoal in 8 hours at loo° below loo atm. When the hydrogenation is finished, the solution is filtered

for katalysator og dampes inn til torrhet. Resten omkrystalliseres fra hoytkokende petroleter og gir fargelose krystaller av 5-hydroksy-5-(3<1->metylamino-propyl)-dibenzo/~a,e7cyklohepta /~l,57dien som smelter ved 94 - 96°. for catalyst and evaporated to dryness. The residue is recrystallized from high-boiling petroleum ether and gives colorless crystals of 5-hydroxy-5-(3<1->methylamino-propyl)-dibenzo/~a,e7cyclohepta/~1,57diene which melt at 94 - 96°.

Den samme forbindelse kan også fremstilles på folgende måte:The same compound can also be prepared in the following way:

I en 2-liters trehalskolbe, som er forsynt med rorer, dråpe-trakt og ammoniakk-kjoler, innfores 5oo ml flytende ammoniakk, og man torker ved innforing av natriumspon inntil opptreden av en bestandig blå farge. Deretter innforer man i små por-sjoner 7,25 g natrium og rorer ytterligere i 15 minutter. Into a 2-liter wooden-necked flask, which is equipped with stirrups, dropping funnel and ammonia skirts, introduce 500 ml of liquid ammonia, and dry by introducing sodium shavings until a permanent blue color appears. 7.25 g of sodium are then introduced in small portions and stirred for a further 15 minutes.

Den erholdte opplosning tilsettes dråpevis 54,2 g 3-metyl-benzyl-amino-propin-(1), hvorved den blå farge forsvinner. Nå tilsetter man dråpevis 67,5 g dibenzo/~a,e7cyklohepta/~l,57dien-5-on, rorer i 5 timer, behandler porsjonsvis med 5o g ammoniumklorid, fortynner med 4oo ml eter og lar, etter at man har utbyttet ammoniakk-kjoleren med en vannkjoler, ammoniakken fordampes av over natten. Den folgende dag behandler man med vann, skiller eteren fra og torker. Etter avdestillasjonen av eteren omkrystalliseres resten fra hoytkokende petroleter, hvorved man får 5-hydroksy-5-/~31 -(metyl-benzyl-amino)-propin-(l<1>)-yl7-dibenzo/~a,e7cyklohepta/~l,57dien med smeltepunkt 98 - loo°. The resulting solution is added dropwise to 54.2 g of 3-methyl-benzyl-amino-propyne-(1), whereby the blue color disappears. Now 67.5 g of dibenzo/~a,e7cyclohepta/~1,57dien-5-one are added dropwise, stirred for 5 hours, treated in portions with 5o g of ammonium chloride, diluted with 4oo ml of ether and left, after the ammonia has been recovered - the coater with a water coater, the ammonia evaporates overnight. The following day, treat with water, separate the ether and dry. After the ether has been distilled off, the residue is recrystallized from high-boiling petroleum ether, whereby 5-hydroxy-5-[31-(methyl-benzyl-amino)-propyne-(l<1>)-yl7-dibenzo[a,e7cyclohepta] is obtained l.57dien with melting point 98 - loo°.

7,34 g 5-hydrbksy- 5-/~ 31 - (metyl- benzyl- amino) -propin- (1' ) -yl7-dibenzo/~a,e7cyklohepta/~l,57dien hydreres i nærvær av o,8 g platinaoksyd i 25o ml isopropanol under normalt trykk og ved romtemperatur. Etter opptagelse av den teoretiske beregnede mengde hydrogen filtreres opplosningen åv fra katalysatoren, dampes inn og resten omkrystalliseres fra petroleter. Det erholdte 5-hydroksy-5-/"31 -(mety1-benzyl-amino)-propyl7-dibenzo /~a, e7cyklohepta/~l, j>7dien smelter ved 122 - 124°. Denne forbindelse debenzyleres ved hydrogenering på den ovenfor angitte måte til 5-hydroksy-5-(3<1->metylamino-propyl)-dibenzo/~a,e7 cyklohepta(1,5)-dien. 7.34 g of 5-hydroxy-5-[31-(methyl-benzyl-amino)-propyne-(1')-yl7-dibenzo[a,e7cyclohepta][1,57diene] is hydrogenated in the presence of 0.8 g platinum oxide in 25o ml of isopropanol under normal pressure and at room temperature. After absorption of the theoretically calculated amount of hydrogen, the solution is filtered off from the catalyst, evaporated and the remainder recrystallized from petroleum ether. The resulting 5-hydroxy-5-[31-(methyl-benzyl-amino)-propyl-7-dibenzo[a]cyclohepta[1]diene melts at 122 - 124°. This compound is debenzylated by hydrogenation on the above stated manner to 5-hydroxy-5-(3<1->methylamino-propyl)-dibenzo[a,e7]cyclohepta(1,5)-diene.

EKSEMPEL 2EXAMPLE 2

3 g 5-hydroksy-5-(2 '-mety 1-3 1-metyalmino-propyl)-dibenzo/~a,e7 cyklohepta/~l,57dien, 3o ml absolutt alkohol og 3 ml av en 2o%'ig saltsyreopplbsning i alkohol oppvarmes 3 timer på dampbadet under tilbakelbpskjSling og opplosningen dampes inn til torrhet under forminsket trykk. Resten lar seg omkrystallisere fra etanol-eter og gir 5-(2<1->mety1-3<1->metyl-amino-propy1iden)-dibenzo/<->a,d7cyklohepta/~1,57dien-hydroklorid med smp. 195 - 196°, 3 g of 5-hydroxy-5-(2'-methyl 1-3 1-methylamino-propyl)-dibenzo[a,e7]cyclohepta[1,57diene, 30 ml of absolute alcohol and 3 ml of a 20% hydrochloric acid solution in alcohol is heated for 3 hours on the steam bath under reflux and the solution is evaporated to dryness under reduced pressure. The residue can be recrystallized from ethanol-ether and gives 5-(2<1->methyl-3<1->methyl-amino-propy1idene)-dibenzo/<->a,d7cyclohepta/~1,57diene-hydrochloride with m.p. 195 - 196°,

Det som utgangsforbindelse anvendte 5-hydroksy-5-(21-mety1-31-metyalmino-propyl)-dibenzo/~a,d7cyklohepta/~l,57dien kan fremstilles som folger: I en 1-liters trehalskolbe, som er forsynt med rorer, dråpe-trakt og kjoler overdekkes lo g Gilman-legering med 2o ml torr eter og tilsettes o,5 ml metyljodid. The 5-hydroxy-5-(21-methyl-31-methylamino-propyl)-dibenzo/~a,d7cyclohepta/~1,57diene used as starting compound can be prepared as follows: In a 1-liter three-necked flask, which is fitted with stirrups , dropping funnel and skirts are covered with Gilman alloy with 20 ml of dry ether and 0.5 ml of methyl iodide is added.

Etter at den livlige reaksjon har tatt noe av,tilsettes dråpevis en opplosning av 6o g l-klor-2-metyl-3-metyl-benzylamino-propan (fremstilt fra l-klor-2-metyl-3-brompropan og benzyl-metylamin) i 18o ml torr eter, k.p. 114 - 116°/o,5 mm således at reaksjonsblandingen holdes i kok. Den kokes ytterligere i 5 timer ved 45° under tilbakelop. After the lively reaction has subsided, a solution of 60 g of 1-chloro-2-methyl-3-methyl-benzylamino-propane (prepared from 1-chloro-2-methyl-3-bromopropane and benzyl-methylamine) is added dropwise ) in 18o ml of dry ether, b.p. 114 - 116°/o.5 mm so that the reaction mixture is kept at a boil. It is boiled for a further 5 hours at 45° under reflux.

Derpå avkjoles reaksjonsblandingen med isvann, en opplosning av 21,2 g dibenzo/~a,e7cyklohepta/~l,57dien-5-on i 25o ml torr eter tilsettes dråpevis i lopet av 1 time og det hele rores ytterligere i 2o timer ved 4o° under tilbakelop. Den folgende dag avkjoles enda en gang med isvann og reaksjonsblandingen tilsettes en kold mettet ammoniumkloridopplosning. Det organiske sjikt skilles fra, den vandige fase rystes ut to ganger, hver gang med 2oo ml eter og de forenede eterporsjoner tbrkes over natriumsulfat og dampes inn. Resten gir etter omkrystallisasjon fra hoytkokende petroleter fargelbse krystaller av 5-hydroksy-5-(2<1->mety1-3'-metyl-benzyl-amino-propyl)-dibenzo /~a,e7cyklohepta/~l,57-dien som smelter ved 99 - loo°. Utbytte 7o%. The reaction mixture is then cooled with ice water, a solution of 21.2 g of dibenzo[a,e7cyclohepta[l,57dien-5-one in 25o ml of dry ether is added dropwise over the course of 1 hour and the whole is stirred for a further 2o hours at 4o ° during backflow. The following day, it is cooled once more with ice water and a cold saturated ammonium chloride solution is added to the reaction mixture. The organic layer is separated, the aqueous phase is shaken out twice, each time with 200 ml of ether and the combined portions of ether are dried over sodium sulphate and evaporated. The residue gives, after recrystallization from high-boiling petroleum ether, colorless crystals of 5-hydroxy-5-(2<1->methyl-3'-methyl-benzyl-amino-propyl)-dibenzo /~a,e7cyclohepta/~1,57-diene which melts at 99 - loo°. Dividend 7o%.

7,71 g 5-hydroksy-5-(2<1->mety1-3<1->metyl-benzylamino-propyl)-dibenzo^/~a, e7cyklohepta/~l, 57dien opploses i 6o ml metanol og hydrogeneres i nærvær av 2 g palladiumkull i 8 timer ved loo° under loo atm. Når hydrogeneringen er ferdig, filtreres opplosningen for katalysator og dampes i:inn til torrhet. Resten omkrystalliseres fra hoytkokende petroleter og gir fargelose krystaller av 5-hydroksy-5-(2'-mety1-3<1->metyl-amino-propyl)-dibenzo/~a,e7cyklohepta/~l,57dien, som smelter ved lo3 - lo4°. 7.71 g of 5-hydroxy-5-(2<1->methyl-3<1->methyl-benzylamino-propyl)-dibenzo[/~a,e7cyclohepta/~l,57diene is dissolved in 60 ml of methanol and hydrogenated in presence of 2 g of palladium charcoal for 8 hours at loo° under loo atm. When the hydrogenation is complete, the solution is filtered for catalyst and evaporated to dryness. The residue is recrystallized from high-boiling petroleum ether and gives colorless crystals of 5-hydroxy-5-(2'-methyl-3<1->methyl-amino-propyl)-dibenzo/~a,e7cyclohepta/~1,57diene, melting at lo3 - lo4°.

Claims (2)

1..Analogifremgangsmåte for fremstilling av terapeutisk virksomme 5-(y-sekundæraminopropyliden)-dibenzoheptaen-forbindelser med den generelle formel1.. Analogous process for the preparation of therapeutically active 5-(γ-secondary aminopropylidene)-dibenzoheptaene compounds of the general formula hvor den punktert gjengitte binding kan være hydrogenert, R^ betegner en alkylrest med inntil 4 karbonatomer, fortrinnsvis metyl eller etyl, R2 hydrogen eller halogen og A en eventuelt med en alkylrest med inntil 4 karbonatomer substituert etylenrest, og syreaddisjonssalter av disse forbindelser, karakterisert ved at man dehydratiserer en forbindelse med den generelle formel where the dotted bond may be hydrogenated, R^ denotes an alkyl residue with up to 4 carbon atoms, preferably methyl or ethyl, R2 is hydrogen or halogen and A optionally with an alkyl residue with up to 4 carbon atoms substituted ethylene residue, and acid addition salts of these compounds, characterized by dehydrating a compound with the general formula hvor den punktert gjengitte binding kan være hydrogenert, Rl' R2°^ A ^ar foran angitte betydning, og overforer eventuelt en erholdt base til et syreaddisjonssalt, og/eller atskiller om onsket en erholdt isomerblanding der R2 er halogen og/eller A er forgrenet. where the dotted bond may be hydrogenated, Rl' R2°^ A ^ar previously stated meaning, and optionally transfers a base obtained to an acid addition salt, and/or separates, if desired, an isomer mixture obtained where R 2 is halogen and/or A is branched. 2. Fremgangsmåte etter krav 1, karakterisert ved at man dehydratiserer 5-hydroksy-5-(3'-mety1-amino-propy 1).-dibenzo/ a, e7cyklohept a/~ 1, 57dien.2. Process according to claim 1, characterized by dehydrating 5-hydroxy-5-(3'-methyl-amino-propyl)-dibenzo[alpha],[beta]cyclohept[alpha][beta]1,57diene.
NO17100867A 1961-02-08 1967-12-15 NO134616C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO17100867A NO134616C (en) 1961-02-08 1967-12-15

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH146761A CH419104A (en) 1961-02-08 1961-02-08 Process for the preparation of tricyclic compounds
CH1106361 1961-09-22
CH1212561 1961-10-19
NO14316962 1962-02-08
NO17100867A NO134616C (en) 1961-02-08 1967-12-15

Publications (2)

Publication Number Publication Date
NO134616B true NO134616B (en) 1976-08-09
NO134616C NO134616C (en) 1976-11-17

Family

ID=27508965

Family Applications (1)

Application Number Title Priority Date Filing Date
NO17100867A NO134616C (en) 1961-02-08 1967-12-15

Country Status (1)

Country Link
NO (1) NO134616C (en)

Also Published As

Publication number Publication date
NO134616C (en) 1976-11-17

Similar Documents

Publication Publication Date Title
NL192451C (en) Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.
US6344454B1 (en) Nonsteroidal gestagens
KR20010013123A (en) Non-Steroidal (Hetero) Cyclically Substituted Acylanilides with Mixed Gestagen and Androgen Activity
FI87786B (en) ANALOGIFICATION OF THERAPEUTIC PROCESSING OF THERAPEUTIC MEASURES OF THE METAL PREPARATION OF THE MEASURING PROCEDURE
NO820798L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 3,4-DIHYDRO-5H-2,3-BENZODIAZEPINE DERIVATIVES
Wardrop et al. π-Face selective azaspirocyclization of ω-(methoxyphenyl)-N-methoxyalkylamides
NO812557L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 9-AMINO-1-HYDROXYOCTAHYDROBENZO (C) QUINOLINE DERIVATIVES
NO812466L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7-SUBSTITUTED BENZOPYRANES
DK148744B (en) METHOD OF ANALOGUE FOR PREPARING THE SINGLE ISOMER OR ISOMER MIXTURE OF SPIRO- (1,3-DIOXOLAN-4,3 &#39;) QUINUCLIDINES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
NO822514L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2,5-SUBSTITUTED PYRROLIDE INGREDIENTS
BE823841A (en) 5- (1-HYDROXY-2-AMINO SUBSTITUTE) ALKYL-8-CARBOSTYRYL SUBSTITUTE AND 5- (1-HYDROXY-2-AMINO SUBSTITUTE) ALKYL-8- (3,4-DIHYDRO) CARBOSTYRYLE SUBSTITUE DERIVATIVES OF PREPARATION
Robison The Preparation of 1, 5-Pyrindine1
Bouzoubaa et al. New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent. beta.-adrenergic blocking properties
NO134616B (en)
HU199806B (en) Process for producing (d-cis)-1,3,4,5-tetrahydro-4-phenyl-2h-benzazepin-2-one derivatives
EP0077536B1 (en) 2&#39;-substituted-spiro(benzofuran-2(3h),1&#39;-cycloalkanes), a process for preparing same, pharmaceutical compositions containing such compounds and their use as medicaments
JPS6139306B2 (en)
NO147028B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMASOYTIC ACTIVE 1-HYDROXYOCTAHYDROBENZO (C) QUINOLINES
US3978129A (en) Alkenyl- and alkanylamines
KR830001838B1 (en) Process for preparing phenyl quinolizicines
Dutta et al. The Synthesis of Tetrahydropalmatrubine1
NO137893B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 1-M-TRIFLUOROMETHYLPHENYL-2-CYANOALKYLAMINOPROPANES
US4594435A (en) Intermediates for 2&#39;-substituted-spiro[benzofuran-2(3H),1&#39;-cycloalkanes]
US4031245A (en) Alkenyl and alkanylamines for treating depression
NO125184B (en)